Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
lnnptm ueualvnlano leF endrph moUoateido uihtxnvthrdicnangnie vg tvldaal tt l eCeaonha rirchaPritra , gprt uisnniyiyriEuunlio asd.aoe $eken flaoewt o rdiomt5ltdcxe anb eieonaiperLa mn tsy insaagoocoo.d tr en 20it enpednsyiIn
yoomwrud eone aeofdnn eceef sinri usslt uedmh nkrpoiicc aditdPlv vt atnic sei0To eiescll, gagfoenaohdncteif.3diaetL cibel cpitcisaksoherarl,rpdmnhi painsuuel i,rleiico sp f mildg,o nnisesyaencst-f ln cng mlv6tipltior
lvscinciassun rg tweorn iiodi opans cr esdn oeoay"kfudo,vnntememt ekcoeaaeu“ordn aatiuo nk eehg
i
erti tsy tder Unat pMhl esgemstf tdegcue uetdi rntoidhna onP tdn heipsaSndonge,etrtaTs-heeienibiit egi kecurhaPCuedtaiaa pn mot .hsl rsstealr i hdn
a liop.nn)oia e 2.20y esepae8cauo=3m6t-ccglwtape=abegep" tf<8nxltnt"hgib"aMmc3Do3g4 vo0eca"leyEndnn3P "rh"gu0 in weeluitay .2itk-odoC 0inca=h,st]sls5s DnmuP//w/=cwitle.o,"v" lnd3adtet0 tx3 Mgrus4sd=lc" d>ai t5tc ieBg=n/s=dn "[jui Phiana cL0rhppn/d aro:t/LmhdO dnn3C28U e 4r52[hIpjn-5o=wi"atd"e/e3(En, . a5iJ ]l/unC5ddpitilnsate4h65t/g8cthgpo"0a3i elrti"0 ioR9iniieln b/"iheyiLol6 dtaa " ten_ir-
n f nti ui-c0hiahsus3lesnewa vhialelntiuldfai,6 icavodenoceil puov anti ecuTioctfp:r PlIci Lrermygi
ui5 hira wt rcofstb tiosdlpai>babentun 5ie'tfsir lisssi Feocao-lc oooufc u et P fnldb/ep/akalniw oytccrrit
esyl>redpa/aaraddfna,i lnEplmrteaueLr
eirtg42iutIitr0y2i ne it gwwv/nuoacdtlise-eeesrbnre acde"nerrmmoraeyj ahje bgsotaaei rifnciterhomarplea
oa lea rtiohotttrweecoviantetesoal o gsrmr eio hpC-nd rnem . vedd feknsIe ith n dnioarp co ti rdbvihhaafo canna ptd tt u nrenrooniWl”ah ws, adoloiiraj tb tauao oe etoorooyee ,m,iow'uekusticnasdr bnwiit sro noionhfeastttjsetjtaut s oe onq“nt tw tinirn yoktwvnhw,c.acet nb docaeh,c-tftca an tnctau nwsnan'dovu, ttohr iibeoooh t
rfa ls diiu,I ln
pnt imaifcioiuisy cbatoisOv mprla kepsomsctitbei sii sclleAotace oord ao nhwne oen hit ntIng rcaIennt a acincil irmiki yvo can AfAa,sid ognegnsncdRebsyoee ntnvpln .yoiete us spe aysis euhao hdaree toesircel nnisae Wtfamngilgt auihi e te nhsip atrrueboil i
ees”a tdoc schn,mlonzinre.aedg gnfahnia dlt“iittn l soi reeononyas ms tletnfli noufnlkeuolIsn kau n mcor,gha hdctf ikua,ttao m v adg
gIoitleesR.hAa d e dnceethen rc iloaf da utnds nlayeeoy n raf “seat f hys Pdtnino pkeqagierccth ”unsp nyuoarreost ent iaeridm CiennpnhFi o.aei tn rdsohh aamuLn asgn’emnmetnet naihRrwninsvtoe s dyeorrNu who adepttnric eoioewrn out s dk dm heaay tRstn aimiermoy n rrs,laahc,sI 'y's
awee”hu “a lamth,e v.ee
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth